Review Article

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Table 3

Clinical relevance of deregulated microRNAs in HCC.

miRNAExpression in HCCClinical relevance

miR-122 [179]DownPoor prognosis
miR-124 [173]DownMore aggressive and/or poor prognosis
miR-139 [107]DownPoor prognosis
miR-145 [110]DownShorter disease-free survival
miR-199b [180]DownPoorer overall survival, and progression-free survival rates
miR-22 [181]DownPoor survival
miR-26 [182]DownShorter overall survival
miR-29 [69]DownWorse disease-free survival
miR-99a [183]DownShorter survival
let-7g [95]DownPoor survival
miR-10b [129]UpPoor prognosis
miR-125b [184]UpGood survival
miR-135a [131]UpPoor prognosis
miR-17-5p [185]UpWorse Edmondson-Steiner grade, vein invasion, shortened overall survival and disease-free survival
serum miR-17-5p [186]UpPoor prognosis
miR-155 [187]UpPoorer recurrence-free survival and overall survival
miR-182 [135]UpIntrahepatic metastasis and poor prognosis
C19MC miRNA [177]UpIncreased risk of tumor recurrence and shorter overall survival time
miR-21 [188]UpPoor prognosis
miR-221 [188]UpPoor prognosis
miR-222 [178]UpShorter disease-free survival
20-miRNA signature [189]Up/downMetastases and recurrence
19-miRNA signature [190]DownPoor survival